Sign up
Tech Capital

Frontier IP investee company achieves major milestone in GSK collaboration

Exscientia has delivered a lead molecule using artificial intelligence
Using AI proved more efficient than traditional screening methods

Frontier IP PLC (LON:FIPP) shares rose on Thursday as the firm said its investee company Exscientia has reached its first major milestone in its collaboration with drugs giant GlaxoSmithKline PLC (LON:GSK) by delivering a lead molecule identified using artificial intelligence.

The drug candidate will target chronic obstructive pulmonary disease, which affects 384mln people globally.

READ: Frontier IP shares lifted as portfolio value jumps 27% in first half

Using the Centaur Chemist AI platform, researchers were able to cut the number of candidate molecules screened when compared with traditional drug discovery methods.

Andy Bell, chief research officer of Exscientia, said: "Our AI platform and approach have advanced significantly over the past few years and have been constantly refined and optimised through real-world projects for our pharma partners.

“With the productivity improvements we are now seeing, we believe that our Centaur Chemist approach is proving itself to be the industry's leading AI-drug discovery platform by achieving far superior results to what conventional discovery techniques have historically delivered."

Frontier IP, which specialises in commercialising university intellectual property, has a 3.32% stake in the drug discovery group.

In afternoon trading, shares in Frontier IP were 3.6% higher at 86p.

 -- Adds share price --

Why Invest In Frontier IP Group PLC? Read More Here

Register here to be notified of future FIPP Company articles
View full FIPP profile View Profile
View All

Related Articles

© tech Capital 2019

Tech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed tech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Tech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Technology market.